Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd Delicata Pocket BR.
Sponsor study identifier
interventional
52
1 country
1
Study Start
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2008
Actual (reported)Study Completion
Not reported
Date not reportedThe purpose of this study is to demonstrate the absence of irritation potential (primary dermal irritability and cumulated dermal irritability) and allergy (sensibilization) of the product Dermacyd Pocket BR.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
January 2008
Actual (reported)April 23, 2008
Actual (reported)April 29, 2008
Actual (reported)The absence of primary and accumulated dermal irritability and dermical sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale.
six weeks
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Sanofi-aventis administrative office
São Paulo, São Paulo, Brazil
Jaderson Lima
Sanofi-aventis administrative office Brazil
52 participants (actual enrollment reported by the registry).
First Submitted
April 23, 2008
First Posted
April 29, 2008
Study Start
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
Dermacyd Tina Gel Sweet Flower - Photo Evaluation
Contact the study team to confirm eligibility.
Primary Completion
January 2008
Actual (reported)Last Updated
January 29, 2009
Record last verified: 2009-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: